摘要:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
摘要:
An apparatus for the transfer of broadband, high-frequency signals of a center wavelength (λc), including a conductor structure, which includes at least one signal path and two reference paths arranged symmetrically to the signal path. Together the conductor structure and the two reference paths form a coplanar line, with the conductor structure being arranged on two oppositely lying sides of at least one dielectric substrate layer of a predetermined thickness in such a manner that the conductor structure overlaps in predetermined coupling regions, whereby the coupling region of the conductor structure transfers the high-frequency signals by an electromagnetic coupling, wherein the thickness of the substrate layer (18) is smaller than λc/4, and wherein multiple electromagnetic couplings are arranged serially one after the other. The apparatus enables a galvanic isolation having good transfer properties in the case of frequencies greater than 6 GHz.
摘要:
The present invention provides a process for preparing particles of magnesium halide/alcohol adduct, said process comprising: preparing a melt of magnesium halide/alcohol adduct in an inert liquid medium, dispersing the mixture of the inert liquid medium and the melt of the magnesium halide/alcohol adduct by high-speed rotation under a high-gravity field to obtain a dispersion of magnesium halide/alcohol adduct melt; and the cooling the dispersion of the melt to form the particles of magnesium halide/alcohol adduct. The present invention further relates to the particles of magnesium halide/alcohol adduct prepared by the process of the present invention and the use thereof in the preparation of catalysts for olefin polymerization.
摘要:
A method for the inhibition of the binding of α4β1 integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit this binding; pharmaceutically active compositions comprising such compounds; and to the use of such compounds either a above, or in formulations for the control or prevention of diseases states in which α4β1 is involved.
摘要:
The present invention provides a process for preparing particles of magnesium halide/alcohol adduct, said process comprising: preparing a melt of magnesium halide/alcohol adduct in an inert liquid medium, dispersing the mixture of the inert liquid medium and the melt of the magnesium halide/alcohol adduct by high-speed rotation under a high-gravity field to obtain a dispersion of magnesium halide/alcohol adduct melt; and the cooling the dispersion of the melt to form the particles of magnesium halide/alcohol adduct. The present invention further relates to the particles of magnesium halide/alcohol adduct prepared by the process of the present invention and the use thereof in the preparation of catalysts for olefin polymerization.
摘要:
FIG. 1 is a front, top perspective view of a mosquito killer lamp, showing my new design; FIG. 2 is a rear, bottom perspective view thereof; FIG. 3 is a left side view thereof; FIG. 4 is a right side view thereof; FIG. 5 is a rear elevation view thereof; FIG. 6 is a front elevation view thereof; FIG. 7 is a top plan view thereof; FIG. 8 is a bottom plan view thereof; FIG. 9 is an enlarged view of detail “9” identified in FIG. 1; and, FIG. 10 is another perspective view of the mosquito killer lamp, shown in an alternative position. The dashed broken lines in the figures illustrate portions of the mosquito killer lamp that form no part of the claimed design. The dash dot dash broken lines in FIGS. 1 and 9 are for the purpose of illustrating the enlarged view indicators and form no part of the claimed design.
摘要:
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
摘要:
Variant sucrose transporter polypeptides that enable faster sucrose utilization in bacteria are described. Additionally, variant or recombinant bacteria comprising these variant sucrose transporter polypeptides, and methods of utilizing the bacteria to produce products such as glycerol and glycerol-derived products are provided.
摘要:
Mechanisms for performing database queries are provided. With these mechanisms, in response to a query request, a query plan intended for minimum query response time and a query plan intended for minimum query total time for the query request are obtained execution of the minimum query response time query plan and the minimum query total time query plan is started. Before the execution of the minimum query total time query plan reaches a specified point, an initial query result obtained from the execution of the minimum query response time query plan is output. In response to the execution of the minimum query total time query plan reaching the specified point, continuing the execution of the minimum query total time query plan to output remaining query results.
摘要:
Recombinant bacteria having an improved ability to utilize sucrose are provided. These recombinant bacteria have nucleotide sequences encoding sucrose utilization polypeptides integrated into their genome between the yihP gene or its homolog and the yihO gene or its homolog. Additionally, methods of utilizing the recombinant bacteria to produce products such as glycerol and glycerol-derived products are provided.